Pancreatic cancer vaccine may improve survival

An experimental pancreatic cancer vaccine seems to be nudging survival rates higher for this aggressive, often-fatal malignancy for which there are few treatment options.

Use of the vaccine improves the 2-year survival of patients who have surgery to remove the tumor from about 42 percent to 76 percent, according to the results of a phase II trial presented Tuesday at a cancer meeting in Philadelphia.

Still, the authors emphasize that the findings are preliminary and further follow-up is needed.

The vaccine, which has shown encouraging results in an initial phase I trial, is designed to boost the patient’s immune responses to pancreatic cancer cells that may be left behind after surgery and chemotherapy and radiation.

In the phase II trial, the vaccine, which was given to 60 patients with resected pancreatic cancer, was associated with 1- and 2-year survival rates of 88 percent and 76 percent, respectively. Previous studies have typically yielded corresponding survival rates of 63 percent and 42 percent.

In comments to Reuters Health, study investigator Dr. Daniel Laheru, from Johns Hopkins Kimmel Cancer Center in Baltimore cautioned that while the findings are potentially good news for patients with early stage disease, “only about 15 percent to 20 percent” of patients with the malignancy fit into this category.

“Clearly, the majority of patients have advanced disease at presentation,” he said. He also said that his group completed a study last year using a similar vaccine in patients with advanced pancreatic cancer and “we’ve just submitted the results for publication.”

RELATED STORIES:
Pancreatic cancer affects blacks at higher rates   Age important in hereditary pancreatic cancer risk   Surgery and Adjuvant Therapy Can Work for Pancreatic Cancer   A promising approach in the prevention and treatment of pancreatic cancer   Patients With Pancreatic Cancer Could be Treated   DNA Repair Patterns May Predict Risk of Pancreatic Cancer   Researchers ID Gene Involved in Pancreatic Cancer   Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others   Avastin trial for pancreatic tumors   Gene Discovered by Researchers Tied to Pancreatic Cancer   Alcohol Consumption May Increase Pancreatic Cancer Risk   Daily drinking may raise risk of several cancers   Study links sugary soft drinks to pancreatic cancer   Rare pancreatic cancer patients may live longer when treated with radiation therapy   Pancreatic cancer and ecoendoscop   Insulin Levels and Resistance Linked to Risk of Pancreatic Cancer   Pancreatic Tumors Are Marked for Immunotherapy   Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half   Researchers Identify Biomarkers of Early-stage Pancreatic Cancer in Mice and Man   Nanoscopic changes to pancreatic cells reveal cancer   Hepatitis B Exposure May Increase Risk For Pancreatic Cancer   Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]